226 related articles for article (PubMed ID: 20528949)
21. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro.
Ramage G; Jose A; Coco B; Rajendran R; Rautemaa R; Murray C; Lappin DF; Bagg J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):456-60. PubMed ID: 21310633
[TBL] [Abstract][Full Text] [Related]
22. In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi.
Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Pesti M; Papp T; Vágvölgyi C
FEMS Microbiol Lett; 2010 Jun; 307(2):175-84. PubMed ID: 20636975
[TBL] [Abstract][Full Text] [Related]
23. Extracellular phospholipase production of oral Candida albicans isolates from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to polyene, echinocandin and azole antimycotics.
Ellepola AN; Samaranayake LP; Khan ZU
Braz J Microbiol; 2016; 47(4):911-916. PubMed ID: 27522928
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods.
Guo N; Wu X; Yu L; Liu J; Meng R; Jin J; Lu H; Wang X; Yan S; Deng X
FEMS Immunol Med Microbiol; 2010 Mar; 58(2):193-201. PubMed ID: 19878317
[TBL] [Abstract][Full Text] [Related]
25. [Activity of the azole drugs in vitro against strains of Candida albicans with different codes isolated from the digestive tract in children].
Kurnatowski M; Kurnatowska A; Wasowska-Królikowska K
Wiad Parazytol; 2004; 50(3):387-92. PubMed ID: 16865942
[TBL] [Abstract][Full Text] [Related]
26. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
[TBL] [Abstract][Full Text] [Related]
27. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
Lynch ME; Sobel JD
J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
[TBL] [Abstract][Full Text] [Related]
28. Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells.
Chen J; Bai H; Wang C; Kang J
Pharmazie; 2006 Aug; 61(8):710-6. PubMed ID: 16964716
[TBL] [Abstract][Full Text] [Related]
29. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
Wei GX; Bobek LA
J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
[TBL] [Abstract][Full Text] [Related]
30. Study of the activity of Punica granatum-mediated silver nanoparticles against Candida albicans and Candida glabrata, alone or in combination with azoles or polyenes.
Souza JAS; Alves MM; Barbosa DB; Lopes MM; Pinto E; Figueiral MH; Delbem ACB; Mira NP
Med Mycol; 2020 Jun; 58(4):564-567. PubMed ID: 31509195
[TBL] [Abstract][Full Text] [Related]
31. Synergistic fungicidal activity of the lipopeptide bacillomycin D with amphotericin B against pathogenic Candida species.
Tabbene O; Di Grazia A; Azaiez S; Ben Slimene I; Elkahoui S; Alfeddy MN; Casciaro B; Luca V; Limam F; Mangoni ML
FEMS Yeast Res; 2015 Jun; 15(4):fov022. PubMed ID: 25956541
[TBL] [Abstract][Full Text] [Related]
32. Synergistic Antifungal Activity of Isoquercitrin: Apoptosis and Membrane Permeabilization Related to Reactive Oxygen Species in Candida albicans.
Kim S; Woo ER; Lee DG
IUBMB Life; 2019 Feb; 71(2):283-292. PubMed ID: 30481395
[TBL] [Abstract][Full Text] [Related]
33. Effect of azoles on the secretion of a Candida albicans metallopeptidase.
Imbert C; Imbert-Bouyer S; Kauffmann-Lacroix C; Daniault G; Rodier MH
Mycopathologia; 2006 Mar; 161(3):147-52. PubMed ID: 16482386
[TBL] [Abstract][Full Text] [Related]
34. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.
Hitchcock CA; Russell NJ; Barrett-Bee KJ
Crit Rev Microbiol; 1987; 15(1):111-5. PubMed ID: 3319418
[TBL] [Abstract][Full Text] [Related]
35. In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata.
Defontaine A; Bouchara JP; Declerk P; Planchenault C; Chabasse D; Hallet JN
J Med Microbiol; 1999 Jul; 48(7):663-670. PubMed ID: 10403417
[TBL] [Abstract][Full Text] [Related]
36. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
37. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
Kutsyk RV; Pavliuk TD
Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
[TBL] [Abstract][Full Text] [Related]
38. The impact of polyene, azole, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection.
Anil S; Ellepola AN; Samaranayake LP
Mycopathologia; 2002; 153(4):179-85. PubMed ID: 12014477
[TBL] [Abstract][Full Text] [Related]
39. Synergistic activity between Echinophora platyloba DC ethanolic extract and azole drugs against clinical isolates of Candida albicans from women suffering chronic recurrent vaginitis.
Avijgan M; Mahboubi M; Moheb Nasab M; Ahmadi Nia E; Yousefi H
J Mycol Med; 2014 Jun; 24(2):112-6. PubMed ID: 24746726
[TBL] [Abstract][Full Text] [Related]
40. The synergistic antifungal activity of resveratrol with azoles against Candida albicans.
Wang J; Zhang X; Gao L; Wang L; Song F; Zhang L; Wan Y
Lett Appl Microbiol; 2021 Jun; 72(6):688-697. PubMed ID: 33550599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
